CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: 5-methoxytryptamine
Accession: CHEBI:2089
browse the term
Definition: A member of the class of tryptamines that is the methyl ether derivative of serotonin.
Synonyms: related_synonym: 2-(5-methoxy-1H-indol-3-yl)ethanamine; 2-(5-methoxyindol-3-yl)ethylamine; 3-(2-aminoethyl)-5-methoxyindole; 5-MT; 5-MeOT; 5-Mot; 5-methoxy-1H-indole-3-ethanamine; 5MOT; Formula=C11H14N2O; InChI=1S/C11H14N2O/c1-14-9-2-3-11-10(6-9)8(4-5-12)7-13-11/h2-3,6-7,13H,4-5,12H2,1H3; InChIKey=JTEJPPKMYBDEMY-UHFFFAOYSA-N; O-methylserotonin; SMILES=COC1=CC2=C(NC=C2CCN)C=C1; mexamine
xref: Beilstein:145587; CAS:608-07-1; Chemspider:1767; FooDB:FDB023311; Gmelin:1220927; HMDB:HMDB0004095; KEGG:C05659; KNApSAcK:C00051985; LINCS:LSM-4582
xref_mesh: MESH:D008735
xref: PDBeChem:F5U; PMID:10420441; PMID:11270479; PMID:12659894; PMID:16007002; PMID:16714247; PMID:17451889; PMID:17601618; PMID:18318189; PMID:22678752; PMID:23098818; PMID:23451999; PMID:25863630; PMID:27112772; PMID:3919158; PMID:9128844; Patent:EP1653948; Patent:WO2005009419; Reaxys:145587; Wikipedia:5-Methoxytryptamine
cyclic_relationship: is_conjugate_base_of CHEBI:166874
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
multiple interactions
ISO
CYP2D6 protein binds to and results in decreased methylation of 5-Methoxytryptamine
CTD
PMID:12777961
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
G
Htr7
5-hydroxytryptamine receptor 7
multiple interactions
ISO
[5-Methoxytryptamine binds to and results in increased activity of HTR7 protein] which results in increased abundance of Cyclic AMP
CTD
PMID:14578406
NCBI chr 1:233,636,442...233,761,063
Ensembl chr 1:233,636,452...233,760,626
G
Kmo
kynurenine 3-monooxygenase
increases expression
EXP
5-Methoxytryptamine results in increased expression of KMO mRNA
CTD
PMID:32243540
NCBI chr13:87,557,080...87,589,334
Ensembl chr13:87,557,286...87,588,881
G
Ppp1r1b
protein phosphatase 1, regulatory (inhibitor) subunit 1B
decreases phosphorylation increases phosphorylation
ISO
5-Methoxytryptamine results in decreased phosphorylation of PPP1R1B protein 5-Methoxytryptamine results in increased phosphorylation of PPP1R1B protein
CTD
PMID:11880652
NCBI chr10:83,347,731...83,356,775
Ensembl chr10:83,347,731...83,356,775
G
Sod2
superoxide dismutase 2
decreases expression
EXP
5-Methoxytryptamine results in decreased expression of SOD2 mRNA
CTD
PMID:32243540
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Taar1
trace-amine-associated receptor 1
increases activity multiple interactions
ISO
5-Methoxytryptamine results in increased activity of TAAR1 protein [5-Methoxytryptamine results in increased activity of TAAR1 protein] which results in increased abundance of Cyclic AMP
CTD
PMID:19725810
NCBI chr 1:21,517,742...21,518,740
Ensembl chr 1:21,517,258...21,532,084
G
Tph1
tryptophan hydroxylase 1
decreases expression
EXP
5-Methoxytryptamine results in decreased expression of TPH1 mRNA
CTD
PMID:32243540
NCBI chr 1:97,157,375...97,178,415
Ensembl chr 1:97,157,409...97,178,344
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
decreases activity multiple interactions
ISO
5-methoxy-N,N-diisopropyltryptamine analog results in decreased activity of CYP2B6 protein [5-methoxy-N,N-diisopropyltryptamine analog results in decreased activity of CYP2B6 protein] which results in decreased metabolism of Bupropion
CTD
PMID:26599973
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
multiple interactions decreases activity
ISO
[5-methoxy-N,N-diisopropyltryptamine analog results in decreased activity of CYP2C19 protein] which results in decreased metabolism of Omeprazole
CTD
PMID:26599973
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Cyp2d1
cytochrome P450, family 2, subfamily d, polypeptide 1
increases metabolic processing
EXP
CYP2D1 protein results in increased metabolism of 5-methoxy-N,N-diisopropyltryptamine
CTD
PMID:18191824
NCBI chr 7:113,908,950...113,913,420
Ensembl chr 7:113,908,947...113,922,084
G
Cyp2d2
cytochrome P450, family 2, subfamily d, polypeptide 2
increases metabolic processing
EXP
CYP2D2 protein results in increased metabolism of 5-methoxy-N,N-diisopropyltryptamine
CTD
PMID:18191824
NCBI chr 7:113,935,138...113,939,209
Ensembl chr 7:113,935,138...113,939,209
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
multiple interactions decreases activity
ISO
[5-methoxy-N,N-diisopropyltryptamine analog results in decreased activity of CYP2D6 protein] which results in decreased metabolism of Dextromethorphan
CTD
PMID:26599973
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
multiple interactions decreases activity
ISO
[5-methoxy-N,N-diisopropyltryptamine analog results in decreased activity of CYP2E1 protein] which results in decreased metabolism of Chlorzoxazone
CTD
PMID:26599973
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all